Bespoke Extracts Inc (BSPK)
0.1282
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
Bespoke Extracts Enterprise Value: 2.200M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 2.200M |
| May 30, 2024 | 2.200M |
| May 29, 2024 | 2.422M |
| May 28, 2024 | 2.422M |
| May 24, 2024 | 2.218M |
| May 23, 2024 | 2.218M |
| May 22, 2024 | 2.218M |
| May 21, 2024 | 1.736M |
| May 20, 2024 | 2.320M |
| May 17, 2024 | 1.913M |
| May 16, 2024 | 1.913M |
| May 15, 2024 | 2.422M |
| May 14, 2024 | 1.781M |
| May 13, 2024 | 1.506M |
| May 10, 2024 | 1.405M |
| May 09, 2024 | 2.422M |
| May 08, 2024 | 1.710M |
| May 07, 2024 | 2.015M |
| May 06, 2024 | 1.894M |
| May 03, 2024 | 1.894M |
| May 02, 2024 | 2.015M |
| May 01, 2024 | 2.116M |
| April 30, 2024 | 2.116M |
| April 29, 2024 | 1.512M |
| April 26, 2024 | 1.837M |
| Date | Value |
|---|---|
| April 25, 2024 | 2.014M |
| April 24, 2024 | 2.014M |
| April 23, 2024 | 2.014M |
| April 22, 2024 | 2.014M |
| April 19, 2024 | 2.014M |
| April 18, 2024 | 2.014M |
| April 17, 2024 | 1.512M |
| April 16, 2024 | 1.662M |
| April 15, 2024 | 1.612M |
| April 12, 2024 | 1.793M |
| April 11, 2024 | 1.793M |
| April 10, 2024 | 1.793M |
| April 09, 2024 | 1.793M |
| April 08, 2024 | 2.015M |
| April 05, 2024 | 2.015M |
| April 04, 2024 | 2.457M |
| April 03, 2024 | 2.457M |
| April 02, 2024 | 2.483M |
| April 01, 2024 | 2.218M |
| March 28, 2024 | 2.086M |
| March 27, 2024 | 2.116M |
| March 26, 2024 | 2.167M |
| March 25, 2024 | 2.432M |
| March 22, 2024 | 2.574M |
| March 21, 2024 | 2.726M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
0.6305M
Minimum
Nov 01 2019
20.53M
Maximum
Jan 22 2021
3.910M
Average
2.788M
Median
Oct 20 2023
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 4.387M |
| Palatin Technologies Inc | 19.03M |
| iBio Inc | 28.91M |
| Theriva Biologics Inc | -10.98M |
| Oragenics Inc | 8.699M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.2691M |
| Revenue (Quarterly) | 0.2638M |
| Total Expenses (Quarterly) | 0.5287M |
| EPS Diluted (Quarterly) | -0.03 |
| Gross Profit Margin (Quarterly) | 61.93% |
| Profit Margin (Quarterly) | -102.0% |
| Earnings Yield | -117.0% |
| Normalized Earnings Yield | -117.00 |